Quick Answer
Microbot Medical Inc. reported Total Revenue of $116.9 thousand for fiscal year 2015.
Microbot Medical Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$13.14M -14.8% |
-$11.44M -6.5% |
-$10.74M +18.4% |
-$13.17M -16.4% |
-$11.31M -23.4% |
-$9.17M -26.5% |
| Diluted EPS | -$0.29 +60.3% |
-$0.73 +30.5% |
-$1.05 +42.0% |
-$1.81 | — | — |
| Total Assets | $81.54M +1252.1% |
$6.03M -27.6% |
$8.33M -12.7% |
$9.54M -43.1% |
$16.77M -36.2% |
$26.28M -29.2% |
| Cash and Equivalents | $3.91M +25.6% |
$3.11M +26.2% |
$2.47M +1.1% |
$2.44M -81.9% |
$13.49M -31.3% |
$19.65M -31.7% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $77.55M +2097.0% |
$3.53M -21.6% |
$4.50M -38.2% |
$7.29M -49.3% |
$14.38M -40.8% |
$24.31M -22.9% |
| R&D Expense | $6.28M -5.2% |
$6.63M +15.8% |
$5.72M -26.0% |
$7.74M +25.7% |
$6.15M +81.2% |
$3.40M +11.4% |
| Operating Income | -$14.74M -26.8% |
-$11.62M -18.0% |
-$9.86M +25.8% |
-$13.28M -16.9% |
-$11.36M -25.0% |
-$9.09M -25.5% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 67.16M +246.2% |
19.40M +65.7% |
11.71M +48.4% |
7.89M +11.0% |
7.11M +0.0% |
7.11M -1.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2016 | $32.8K | -11.5% | +11.8% |
| Net Income | September 30, 2025 | -$3.58M | -11.3% | -2.2% |
| Diluted EPS | September 30, 2025 | -$0.07 | +65.0% | +30.0% |
| Total Assets | September 30, 2025 | $81.76M | +1469.9% | +146.8% |
| Cash and Equivalents | September 30, 2025 | $6.70M | +1299.6% | +64.2% |
| Long-Term Debt | June 30, 2013 | $17.5K | -92.4% | -75.4% |
| Stockholders Equity | September 30, 2025 | $78.22M | +1954.2% | +157.7% |
| R&D Expense | September 30, 2025 | $1.17M | -43.2% | -44.5% |
| Operating Income | September 30, 2025 | -$3.86M | -17.0% | -3.7% |
| Gross Profit | September 30, 2014 | $211.5K | -11.5% | +28.9% |
| Shares Outstanding | September 30, 2025 | 65.83M | +295.4% | +73.4% |
- Microbot Medical Inc. reported Total Revenue of $116.9 thousand for fiscal year 2015.
- Microbot Medical Inc. showed a decrease of -88.5% in Total Revenue compared to the prior fiscal year.
- Microbot Medical Inc. reported Net Income of -$13.14 million for fiscal year 2025.
- Microbot Medical Inc. showed a decrease of -14.8% in Net Income compared to the prior fiscal year.
- Microbot Medical Inc. reported Diluted EPS of $0.29 per share (loss) for fiscal year 2025.
- Microbot Medical Inc. showed an increase of +60.3% in Diluted EPS compared to the prior fiscal year.
- Microbot Medical Inc. reported Total Assets of $81.54 million for fiscal year 2025.
- Microbot Medical Inc. showed an increase of +1252.1% in Total Assets compared to the prior fiscal year.
- Microbot Medical Inc. reported Cash and Equivalents of $3.91 million for fiscal year 2025.
- Microbot Medical Inc. showed an increase of +25.6% in Cash and Equivalents compared to the prior fiscal year.
- Microbot Medical Inc. reported Long-Term Debt of $125.0 thousand for fiscal year 2012.
- Microbot Medical Inc. showed a decrease of -62.3% in Long-Term Debt compared to the prior fiscal year.
- Microbot Medical Inc. reported Stockholders Equity of $77.55 million for fiscal year 2025.
- Microbot Medical Inc. showed an increase of +2097.0% in Stockholders Equity compared to the prior fiscal year.
- Microbot Medical Inc. reported R&D Expense of $6.28 million for fiscal year 2025.
- Microbot Medical Inc. showed a decrease of -5.2% in R&D Expense compared to the prior fiscal year.
- Microbot Medical Inc. reported Operating Income of -$14.74 million for fiscal year 2025.
- Microbot Medical Inc. showed a decrease of -26.8% in Operating Income compared to the prior fiscal year.
- Microbot Medical Inc. reported Gross Profit of $886.6 thousand for fiscal year 2013.
- Microbot Medical Inc. showed a decrease of -19.7% in Gross Profit compared to the prior fiscal year.
- Microbot Medical Inc. reported Shares Outstanding of 67.16 million shares for fiscal year 2025.
- Microbot Medical Inc. showed an increase of +246.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: